Physician profile
Jesse Knight
NPI 1780844431
$1,470.50
in general payments reported to CMS, 2019-2025
14 companies · $307 in 2025
The $307 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.84 · 2020: $13.80 · 2021: $438 · 2022: $191 · 2023: $173 · 2024: $312 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $449.45 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $238.49 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $202.00 | 2021-2025 | Nucala |
| Genzyme Corporation | $162.08 | 2022-2025 | |
| Aerin Medical INC. | $138.78 | 2019-2025 | |
| Optinose US, INC. | $66.18 | 2024-2025 | |
| Smith+Nephew, INC. | $53.85 | 2019-2024 | |
| Innovation Technologies INC | $46.12 | 2025 | Irrisept |
| Stryker Corporation | $29.76 | 2021 | |
| Inspire Medical Systems, INC. | $23.04 | 2023 | Inspire |
| Medtronic, INC. | $16.33 | 2025 | Novapak |
| Merck Sharp & Dohme LLC | $16.26 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.48 | 2025 | Tezspire |
| Merit Medical Systems INC | $12.68 | 2024 | Elation Balloon Dilator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.